Bind Therapeutics: Clinical Trial Update (BIND Therapeutics) - Feb 7, 2016 - Anticipated initiation of stage 2 of P2 iNSITE 2 trial ([NCT02479178) for head and neck cancer by the end of Q1 2016; Anticipated initiation of stage 2 of P2 iNSITE 2 trial ([NCT02479178) in cervical cancer cohort early in Q2 2016
Anticipated trial initiation date • Head and Neck Cancer • Oncology • Uterine Cancer
|